Real-World Data on Cabozantinib in Previously Treated Patients with Metastatic Renal Cell Carcinoma: Focus on Sequences and Prognostic FactorsMatteo Santoni, Nicola Battelli, Umberto Basso et al.|Cancers|2019Cited by 31
Circulating CD137+ T Cells Correlate with Improved Response to Anti-PD1 Immunotherapy in Patients with CancerIlaria Grazia Zizzari, Chiara Napoletano, Alessandra Di Filippo et al.|Clinical Cancer Research|2022Cited by 30
Immunomodulatory effects of tyrosine kinase inhibitors (TKIs) in renal cell carcinoma (RCC) patients.Marianna Nuti, Paolo Marchetti, Ilaria Grazia Zizzari et al.|Journal of Clinical Oncology|2017Cited by 5
Supplementary Figure from Circulating CD137<sup>+</sup> T Cells Correlate with Improved Response to Anti-PD1 Immunotherapy in Patients with CancerIlaria Grazia Zizzari, Chiara Napoletano, Alessandra Di Filippo et al.|Unknown|2023Cited by 0
Supplementary Figure from Circulating CD137<sup>+</sup> T Cells Correlate with Improved Response to Anti-PD1 Immunotherapy in Patients with CancerIlaria Grazia Zizzari, Chiara Napoletano, Alessandra Di Filippo et al.|Unknown|2023Cited by 0